Biometric Medical Security Solutions Investor Deck Q1, 2015

50% of the US population takes prescription medication

The Problem:

1 in 5 teens has abused Rx drugs

70% steal drugs from home, family, friends

98%  don’t lock up drugs at home  

We make unauthorized access easy!

Familiar Brands, Unexpected Results

Opioids – a gateway to Heroin!  

Overdose can occur when sedatives mixed with alcohol  

Stimulants damage decision making capabilities  

Prescription Drugs Cause more than 100 Deaths Each Day in US!

Companies Lose Billions!

Healthcare  facility  the-      Skyrocke1ng  insurance  costs      Increased  Pharma  scru1ny  

Social Price Tag: $600B Annually

Health care costs, traffic accidents, drug related crime and criminal justice, lost work productivity.

A $60 Billion Market Opportunity

Home:  92  Million  households    Healthcare:  $35B  technology    Government:  $24B+  funding    

Government Support for Successful Initiatives Expanding!

President  requests  $25.4  billion  in  Fiscal  Year  (FY)  2015    to  reduce  drug  use  and  its  consequences  in  the  US  

Rx Safe’s Comprehensive Solution

Secure medication lockboxes for use in home and healthcare facilities

Secure medication management and monitoring products

Secure mobile medical stations to administer in home care

Drug drop-boxes to dispose unused medication

Rx Safes’ secured OEM products – medicine carts, PCA, access control and storage

Rx Safes has a Mission as Simple as it is Powerful!

Become the leading provider of standalone biometric medical security solutions for consumer and healthcare markets!

Common Authentication Platform

•  Patented, Best of Breed Biometric Identity Management across product lines

•  Unique Fingerprint for Authentication •  Significant Barrier to Entry Covering Battery

Operated, Portable Biometric Devices –  Highly Accurate Secure and Convenient –  External Integration Through Bluetooth and Wi-Fi

to Mobile Devices and Legacy Systems –  Multiple users and security levels –  Audit Tracking and Reporting – Simplifies

Compliance and Control

Safe at Home Rx DrugSAFE

(In Production)

Safe in the Facility RxDrugSAFE PRO/

Cabinet (Prototype)

Safe in the Field Mobile Medical

Station (Prototype)

Safe in the Future

•  Biometric Controlled Dosing Device

•  Portable HIPAA compliant biometric EMR •  Biometric Tele-Medicine Solutions

•  Biometric Physical and Electronic Health Records

•  Remote Healthcare Monitoring

First Mover Advantage!

•  Multi-Pronged approach to Drug Security and Safety

•  Only Biometric Interface in Portable, Battery Operated Devices to target this market

•  Poor Product Features Hamper existing Competition Obscuring True Market Need

- Professional Narcotic Safes, Medsafe, MedGuard, LockMed, Pill Pod, Safer Lock

- Only Target One Aspect of Drug Diversion issue - Use old, unsecure and inconvenient methods - Not secure or auditable, easy to tamper with

Signed Agreements with McKesson And Cardinal Health - 67% of the retail and professional markets

Federally Funded Government Initiatives

FDA Device Approval – future plan to make product reimbursable through health insurance

Extensive Distribution Already Secured

Additional stakeholders will invest Strategically!

Insurance companies & healthcare providers Demonstrable ROI for drug-abuse prevention

Pharmaceutical companies Under pressure by FDA to show proactively tackling issues caused by their products

The Experience to Execute

Lorraine Yarde, CEO - Pioneer and Leader in standalone biometric products

•  Successfully launched first Nationwide Mass Market Distribution of Consumer Biometric Products– Home Depot, Sears, Costco, Sharper Image

•  Proven ability to create strategic Product Development and Marketing relationships with Brand Name OEMs to develop Fingerprint Products – Master Lock, Black and Decker, Overhead Door Corporation, Honeywell

Projected 77% CAGR

YEAR  ONE   YEAR  TWO   YEAR  THREE  

REVENUE   $2,250,716.31   $5,722,849.74   $12,533.316.60  

EXPENSES   $4,355,006.20   5,458,658.41   $11,517,705.80  

INVESTMENT   $2,500,000  

CASH  ON  HAND   $415,710.11   $679,901,.44   $1,695,512.24  

PROFIT   ($2,084,289.89)   $264,191.33   $1,015,610.80  

$2.5M capital investment will make it happen

PIPE transaction at $xx per share with warrant coverage

Current: 500M common shares par value$0.001 and 50M preferred par value

$0.0001authorized, 125,009,957 common shares, 22,000 preferred shares issued,

11,000,000 options and 550,000 warrants outstanding

An Opportunity for Ground-Floor Investment

First Mover Advantage in Emerging Market Patented Best in Class Technology – Barrier to Entry Robust Product Pipeline Signed Distribution Agreements Proven Leadership $60 billion combined markets  

An Opportunity to Make a Difference!

Improving lives, healthcare & the entire US Economy